News
July 16, 2025 Research and Development
Pharma Foods’ Antibody Technology Advances as Takeda Exercises Sequence Purchase Option
Pharma Foods International Co., Ltd. (hereinafter: PFI) announces that Takeda Pharmaceutical Co., Ltd. has exercised its contractual option to acquire the sequence information of a chicken-derived antibody, generated using PFI’s proprietary antibody discovery platform, ALAgeneⓇ technology.